Early Access — free while we kick the tires
EdgarHawk

Mohamed Elshenawy

CTO

Officer

Latest: CTO selling · June 2026

1 filing analyzed · 1 company · Latest 2026-06-17

Companies

Company Buys Sells Direction
Hims & Hers Health, Inc. HIMS 0 3 Net selling

Activity

June 2026
medium
Sell
30,040 shares
$946,260
Significance 5/10

CTO Mohamed Elshenawy sold 30,040 shares of HIMS at $31.50 under 10b5-1 plan; holds 101.0K shares post-sale.

Mohamed Elshenawy, CTO of Hims & Hers, executed a scheduled sale of 30,040 shares on 2026-06-17 at $31.50 per share under a pre-arranged 10b5-1 trading plan adopted 2025-12-01, reducing his non-derivative holdings from 131.1K to 101.0K shares. The transaction was systematic and predetermined rather than discretionary, meaning timing was not a factor in the trade decision. The current stock price of $31.89 sits -54.7% from the 52-week high of $70.43, while the company reported quarterly revenue of $608.1M with a net loss of $-92.1M and annual revenue growth of +59.0%. The insider maintains substantial derivative holdings of 1,129,964 shares through restricted stock units, indicating continued material stake in the company despite the non-derivative share reduction.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access